Tkachenko E.I., Avalueva E.B., Skazyvaeva E.V., Ivanov S.V., Lapinskii I.V.
SUMMARY
Enterosgel has a positive effect on the clinical performance of the disease and is effective in reducing the symptoms of intestinal dyspepsia and diarrhea in patients with Helicobacter pylori-associated gastroduodenitis.
After a 21-day course of Enterosgel, severity of inflammatory changes in the mucosa of the upper GIT and stomach contamination with Helicobacter pylori significantly reduced in patients with Helicobacter pylori-associated gastroduodenitis, indicating its anti-inflammatory and anti-helicobacter action.
When using Enterosgel in patients with Helicobacter pylori-associated gastroduodenitis, quality of life and psycho-emotional state has improved.
Enterosgel drug was well-tolerated and safe when administered.